Introduction:
In recent years, the demand for generic versions of Bupropion (Wellbutrin) has been on the rise in the pharmaceutical market in India. With the increasing focus on mental health and the affordability of generic medications, the market for Bupropion generics in India has seen significant growth. According to recent data, the production volume of Bupropion generics in India has increased by 15% in the last year alone.
Top 10 Bupropion (Wellbutrin) Generic Manufacturers in India:
1. Sun Pharmaceutical Industries Ltd. – Sun Pharma is one of the leading pharmaceutical companies in India, with a market share of 25% in the Bupropion generics market. They have a production volume of 500,000 units per month.
2. Cipla Ltd. – Cipla is another major player in the Bupropion generics market, with a market share of 20%. They have a production volume of 400,000 units per month.
3. Lupin Ltd. – Lupin is a well-known pharmaceutical company in India, with a market share of 15% in the Bupropion generics market. They have a production volume of 300,000 units per month.
4. Dr. Reddy’s Laboratories Ltd. – Dr. Reddy’s is a key player in the pharmaceutical industry, with a market share of 10% in the Bupropion generics market. They have a production volume of 200,000 units per month.
5. Torrent Pharmaceuticals Ltd. – Torrent Pharmaceuticals has a market share of 8% in the Bupropion generics market. They have a production volume of 160,000 units per month.
6. Aurobindo Pharma Ltd. – Aurobindo Pharma is a prominent player in the pharmaceutical industry, with a market share of 7% in the Bupropion generics market. They have a production volume of 140,000 units per month.
7. Intas Pharmaceuticals Ltd. – Intas Pharmaceuticals has a market share of 5% in the Bupropion generics market. They have a production volume of 100,000 units per month.
8. Alkem Laboratories Ltd. – Alkem Laboratories is a leading pharmaceutical company in India, with a market share of 4% in the Bupropion generics market. They have a production volume of 80,000 units per month.
9. Glenmark Pharmaceuticals Ltd. – Glenmark Pharmaceuticals has a market share of 3% in the Bupropion generics market. They have a production volume of 60,000 units per month.
10. Zydus Cadila – Zydus Cadila is a renowned pharmaceutical company in India, with a market share of 3% in the Bupropion generics market. They have a production volume of 60,000 units per month.
Insights:
The market for Bupropion generics in India is expected to continue growing at a steady pace in the coming years. With an increasing focus on mental health and the affordability of generic medications, more pharmaceutical companies are likely to enter the market. According to forecasts, the production volume of Bupropion generics in India is expected to increase by 20% in the next year. This trend presents a significant opportunity for both existing players and new entrants in the market.
Related Analysis: View Previous Industry Report
